Ubs Asset Management Americas Inc Myriad Genetics Inc Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 200,873 shares of MYGN stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200,873
Previous 375,595
46.52%
Holding current value
$1.35 Million
Previous $1.99 Million
27.18%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding MYGN
# of Institutions
236Shares Held
92.1MCall Options Held
86.1KPut Options Held
18.9K-
Black Rock Inc. New York, NY15.2MShares$102 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.88MShares$52.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.98MShares$33.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.75MShares$31.9 Million0.02% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$30.8 Million0.75% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $541M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...